Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Hoffmann

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptorsI S Hoffmann, R K Talmaciu, R Aquino, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neuronsE Agneter, I S Hoffmann, E A Singer, et al.
Brain Research|September 9, 1996
Comparative dopamine-acetylcholine interactions in the ventral and dorsal striatum of rabbit and rat brainB H Guevara, R K Talmaciu, I S Hoffmann, et al.
British Journal of Cancer|July 1, 1992
Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugsL X Cubeddu, I S Hoffmann, N T Fuenmayor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminalsI S Hoffmann, R K Talmaciu, C P Ferro, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1983
Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidolL X Cubeddu, I S Hoffmann, M K James, et al.
The New England Journal of Medicine|March 22, 1990
Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomitingL X Cubeddu, I S Hoffmann, N T Fuenmayor, et al.
Life Sciences|September 24, 1984
Clonidine reduces elevated cerebrospinal fluid catecholamine levels in patients with essential hypertensionL X Cubeddu, I S Hoffmann, J Davila, et al.
Neuroscience Letters|October 14, 1991
Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slicesL X Cubeddu, I S Hoffmann, R K Talmaciu, et al.
Journal of Human Hypertension|June 2, 2006
NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in HispanicsA M Castejon, J Bracero, I S Hoffmann, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptorsI S Hoffmann, R K Talmaciu, R Aquino, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neuronsE Agneter, I S Hoffmann, E A Singer, et al.
Brain Research|September 9, 1996
Comparative dopamine-acetylcholine interactions in the ventral and dorsal striatum of rabbit and rat brainB H Guevara, R K Talmaciu, I S Hoffmann, et al.
British Journal of Cancer|July 1, 1992
Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugsL X Cubeddu, I S Hoffmann, N T Fuenmayor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminalsI S Hoffmann, R K Talmaciu, C P Ferro, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1983
Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidolL X Cubeddu, I S Hoffmann, M K James, et al.
The New England Journal of Medicine|March 22, 1990
Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomitingL X Cubeddu, I S Hoffmann, N T Fuenmayor, et al.
Life Sciences|September 24, 1984
Clonidine reduces elevated cerebrospinal fluid catecholamine levels in patients with essential hypertensionL X Cubeddu, I S Hoffmann, J Davila, et al.
Neuroscience Letters|October 14, 1991
Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slicesL X Cubeddu, I S Hoffmann, R K Talmaciu, et al.
Journal of Human Hypertension|June 2, 2006
NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in HispanicsA M Castejon, J Bracero, I S Hoffmann, et al.
Pageof 4